Follow the people · Insider
Johanna Mercier
Johanna Mercier files insider transactions with the SEC as a chief comm & corp aff officer of Gilead Sciences (GILD). We hold 8 disclosed purchases and sales filed since 26 July 2019, 3 of them in the last 90 days.
- Files forGILD
- Disclosed buys and sells8 in all, 3 in the last 90 days
- Last disclosure18 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 24 July 2019 — 17 August 2026Chief Comm & Corp Aff Officer · Gilead Sciences (GILD)183 Form 4 lines · source: SEC Form 4
- Filed 15 April 2021 — 27 May 2026Director · Neurocrine Biosciences (NBIX)15 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 23,110 shares of Gilead SciencesSEC Form 418 August 2026Common Stock · traded 17 August 2026 · filed 18 August 2026
- exercised options over 1,890 shares of Gilead SciencesSEC Form 418 August 2026Common Stock · traded 17 August 2026 · filed 18 August 2026
- ▼ sold on the open market 16,530 shares of Gilead SciencesSEC Form 418 August 2026Common Stock · traded 17 August 2026 · filed 18 August 2026
- ▼ sold on the open market 11,470 shares of Gilead SciencesSEC Form 418 August 2026Common Stock · traded 17 August 2026 · filed 18 August 2026
- exercised options over 23,110 shares of Gilead Sciences (a derivative holding)SEC Form 418 August 2026Non-qualified Stock Option (Right to Buy) · traded 17 August 2026 · filed 18 August 2026
- exercised options over 1,890 shares of Gilead Sciences (a derivative holding)SEC Form 418 August 2026Non-qualified Stock Option (Right to Buy) · traded 17 August 2026 · filed 18 August 2026
- ▼ sold on the open market 3,000 shares of Gilead SciencesSEC Form 416 July 2026Common Stock · traded 15 July 2026 · filed 16 July 2026
- ▼ sold on the open market 1,480 shares of Gilead SciencesSEC Form 416 June 2026Common Stock · traded 15 June 2026 · filed 16 June 2026
- ▼ sold on the open market 1,070 shares of Gilead SciencesSEC Form 416 June 2026Common Stock · traded 15 June 2026 · filed 16 June 2026
- ▼ sold on the open market 450 shares of Gilead SciencesSEC Form 416 June 2026Common Stock · traded 15 June 2026 · filed 16 June 2026
- exercised options over 2,796 shares of Gilead SciencesSEC Form 411 June 2026Common Stock · traded 10 June 2026 · filed 11 June 2026
- had shares withheld for tax on 1,341 shares of Gilead SciencesSEC Form 411 June 2026Common Stock · traded 10 June 2026 · filed 11 June 2026
- exercised options over 2,796 shares of Gilead Sciences (a derivative holding)SEC Form 411 June 2026Restricted Stock Unit · traded 10 June 2026 · filed 11 June 2026
- was granted 2,567 shares of Neurocrine Biosciences (a derivative holding)SEC Form 429 May 2026Restriced Stock Unit · traded 27 May 2026 · filed 29 May 2026
- exercised options over 3,318 shares of Neurocrine BiosciencesSEC Form 421 May 2026Common Stock · traded 21 May 2026 · filed 21 May 2026
- exercised options over 3,318 shares of Neurocrine Biosciences (a derivative holding)SEC Form 421 May 2026Restricted Stock Unit · traded 21 May 2026 · filed 21 May 2026
- exercised options over 25,000 shares of Gilead SciencesSEC Form 418 May 2026Common Stock · traded 15 May 2026 · filed 18 May 2026
- ▼ sold on the open market 7,749 shares of Gilead SciencesSEC Form 418 May 2026Common Stock · traded 15 May 2026 · filed 18 May 2026
- ▼ sold on the open market 11,177 shares of Gilead SciencesSEC Form 418 May 2026Common Stock · traded 15 May 2026 · filed 18 May 2026
- ▼ sold on the open market 8,374 shares of Gilead SciencesSEC Form 418 May 2026Common Stock · traded 15 May 2026 · filed 18 May 2026
- ▼ sold on the open market 700 shares of Gilead SciencesSEC Form 418 May 2026Common Stock · traded 15 May 2026 · filed 18 May 2026
- exercised options over 25,000 shares of Gilead Sciences (a derivative holding)SEC Form 418 May 2026Non-qualified Stock Option (Right to Buy) · traded 15 May 2026 · filed 18 May 2026
- ▼ sold on the open market 3,000 shares of Gilead SciencesSEC Form 416 April 2026Common Stock · traded 15 April 2026 · filed 16 April 2026
- ▼ sold on the open market 3,000 shares of Gilead SciencesSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- ▼ sold on the open market 3,000 shares of Gilead SciencesSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- exercised options over 6,617 shares of Gilead SciencesSEC Form 412 March 2026Common Stock · traded 10 March 2026 · filed 12 March 2026
- had shares withheld for tax on 3,216 shares of Gilead SciencesSEC Form 412 March 2026Common Stock · traded 10 March 2026 · filed 12 March 2026
- exercised options over 6,617 shares of Gilead Sciences (a derivative holding)SEC Form 412 March 2026Restricted Stock Unit · traded 10 March 2026 · filed 12 March 2026
- exercised options over 6,617 shares of Gilead Sciences (a derivative holding)SEC Form 412 March 2026Restricted Stock Unit · traded 10 March 2026 · filed 12 March 2026
- was granted 9,590 shares of Gilead Sciences (a derivative holding)SEC Form 412 March 2026Restricted Stock Unit · traded 10 March 2026 · filed 12 March 2026
- was granted 35,880 shares of Gilead Sciences (a derivative holding)SEC Form 412 March 2026Non-qualified Stock Option (Right to Buy) · traded 10 March 2026 · filed 12 March 2026
- was granted 9,590 shares of Gilead Sciences (a derivative holding)SEC Form 412 March 2026Restricted Stock Unit · traded 10 March 2026 · filed 12 March 2026
- was granted 35,880 shares of Gilead Sciences (a derivative holding)SEC Form 412 March 2026Non-qualified Stock Option (Right to Buy) · traded 10 March 2026 · filed 12 March 2026
- exercised options over 6,617 shares of Gilead SciencesSEC Form 412 March 2026Common Stock · traded 10 March 2026 · filed 12 March 2026
- had shares withheld for tax on 3,216 shares of Gilead SciencesSEC Form 412 March 2026Common Stock · traded 10 March 2026 · filed 12 March 2026
- was granted 11,090 shares of Gilead SciencesSEC Form 42 March 2026Common Stock · traded 27 February 2026 · filed 2 March 2026
- was granted 11,090 shares of Gilead SciencesSEC Form 42 March 2026Common Stock · traded 27 February 2026 · filed 2 March 2026
- exercised options over 25,000 shares of Gilead SciencesSEC Form 418 February 2026Common Stock · traded 17 February 2026 · filed 18 February 2026
- ▼ sold on the open market 18,405 shares of Gilead SciencesSEC Form 418 February 2026Common Stock · traded 17 February 2026 · filed 18 February 2026
- ▼ sold on the open market 9,395 shares of Gilead SciencesSEC Form 418 February 2026Common Stock · traded 17 February 2026 · filed 18 February 2026
- exercised options over 25,000 shares of Gilead Sciences (a derivative holding)SEC Form 418 February 2026Non-qualified Stock Option (Right to Buy) · traded 17 February 2026 · filed 18 February 2026
- ▼ sold on the open market 200 shares of Gilead SciencesSEC Form 418 February 2026Common Stock · traded 17 February 2026 · filed 18 February 2026
- exercised options over 25,000 shares of Gilead Sciences (a derivative holding)SEC Form 418 February 2026Non-qualified Stock Option (Right to Buy) · traded 17 February 2026 · filed 18 February 2026
- exercised options over 25,000 shares of Gilead SciencesSEC Form 418 February 2026Common Stock · traded 17 February 2026 · filed 18 February 2026
- ▼ sold on the open market 18,405 shares of Gilead SciencesSEC Form 418 February 2026Common Stock · traded 17 February 2026 · filed 18 February 2026
- ▼ sold on the open market 9,395 shares of Gilead SciencesSEC Form 418 February 2026Common Stock · traded 17 February 2026 · filed 18 February 2026
- ▼ sold on the open market 200 shares of Gilead SciencesSEC Form 418 February 2026Common Stock · traded 17 February 2026 · filed 18 February 2026
- was granted 44,867 shares of Gilead SciencesSEC Form 45 February 2026Common Stock · traded 3 February 2026 · filed 5 February 2026
- had shares withheld for tax on 24,800 shares of Gilead SciencesSEC Form 45 February 2026Common Stock · traded 3 February 2026 · filed 5 February 2026
- was granted 44,867 shares of Gilead SciencesSEC Form 45 February 2026Common Stock · traded 3 February 2026 · filed 5 February 2026
- had shares withheld for tax on 24,800 shares of Gilead SciencesSEC Form 45 February 2026Common Stock · traded 3 February 2026 · filed 5 February 2026
- ▼ sold on the open market 3,000 shares of Gilead SciencesSEC Form 416 January 2026Common Stock · traded 15 January 2026 · filed 16 January 2026
- ▼ sold on the open market 3,000 shares of Gilead SciencesSEC Form 416 January 2026Common Stock · traded 15 January 2026 · filed 16 January 2026
- ▼ sold on the open market 3,000 shares of Gilead SciencesSEC Form 416 December 2025Common Stock · traded 15 December 2025 · filed 16 December 2025
- exercised options over 3,842 shares of Gilead Sciences (a derivative holding)SEC Form 411 December 2025Restricted Stock Unit · traded 10 December 2025 · filed 11 December 2025
- exercised options over 3,842 shares of Gilead SciencesSEC Form 411 December 2025Common Stock · traded 10 December 2025 · filed 11 December 2025
- had shares withheld for tax on 1,814 shares of Gilead SciencesSEC Form 411 December 2025Common Stock · traded 10 December 2025 · filed 11 December 2025
- exercised options over 25,000 shares of Gilead Sciences (a derivative holding)SEC Form 418 November 2025Non-qualified Stock Option (Right to Buy) · traded 17 November 2025 · filed 18 November 2025
- exercised options over 25,000 shares of Gilead SciencesSEC Form 418 November 2025Common Stock · traded 17 November 2025 · filed 18 November 2025
- ▼ sold on the open market 25,524 shares of Gilead SciencesSEC Form 418 November 2025Common Stock · traded 17 November 2025 · filed 18 November 2025
- ▼ sold on the open market 2,476 shares of Gilead SciencesSEC Form 418 November 2025Common Stock · traded 17 November 2025 · filed 18 November 2025
- ▼ sold on the open market 3,000 shares of Gilead SciencesSEC Form 416 October 2025Common Stock · traded 15 October 2025 · filed 16 October 2025
- ▼ sold on the open market 3,000 shares of Gilead SciencesSEC Form 416 September 2025Common Stock · traded 15 September 2025 · filed 16 September 2025
- exercised options over 3,844 shares of Gilead Sciences (a derivative holding)SEC Form 411 September 2025Restricted Stock Unit · traded 10 September 2025 · filed 11 September 2025
- exercised options over 3,844 shares of Gilead SciencesSEC Form 411 September 2025Common Stock · traded 10 September 2025 · filed 11 September 2025
- had shares withheld for tax on 1,819 shares of Gilead SciencesSEC Form 411 September 2025Common Stock · traded 10 September 2025 · filed 11 September 2025
- exercised options over 11,800 shares of Gilead Sciences (a derivative holding)SEC Form 418 August 2025Non-qualified Stock Option (Right to Buy) · traded 15 August 2025 · filed 18 August 2025
- exercised options over 700 shares of Gilead Sciences (a derivative holding)SEC Form 418 August 2025Non-qualified Stock Option (Right to Buy) · traded 15 August 2025 · filed 18 August 2025
- exercised options over 11,800 shares of Gilead Sciences (a derivative holding)SEC Form 418 August 2025Non-qualified Stock Option (Right to Buy) · traded 15 August 2025 · filed 18 August 2025
- exercised options over 700 shares of Gilead Sciences (a derivative holding)SEC Form 418 August 2025Non-qualified Stock Option (Right to Buy) · traded 15 August 2025 · filed 18 August 2025
- exercised options over 11,800 shares of Gilead SciencesSEC Form 418 August 2025Common Stock · traded 15 August 2025 · filed 18 August 2025
- ▼ sold on the open market 11,800 shares of Gilead SciencesSEC Form 418 August 2025Common Stock · traded 15 August 2025 · filed 18 August 2025
- exercised options over 700 shares of Gilead SciencesSEC Form 418 August 2025Common Stock · traded 15 August 2025 · filed 18 August 2025
- ▼ sold on the open market 700 shares of Gilead SciencesSEC Form 418 August 2025Common Stock · traded 15 August 2025 · filed 18 August 2025
- exercised options over 11,800 shares of Gilead SciencesSEC Form 418 August 2025Common Stock · traded 15 August 2025 · filed 18 August 2025
- ▼ sold on the open market 11,800 shares of Gilead SciencesSEC Form 418 August 2025Common Stock · traded 15 August 2025 · filed 18 August 2025
- exercised options over 700 shares of Gilead SciencesSEC Form 418 August 2025Common Stock · traded 15 August 2025 · filed 18 August 2025
- ▼ sold on the open market 700 shares of Gilead SciencesSEC Form 418 August 2025Common Stock · traded 15 August 2025 · filed 18 August 2025
- ▼ sold on the open market 2,800 shares of Gilead SciencesSEC Form 418 August 2025Common Stock · traded 15 August 2025 · filed 18 August 2025
- ▼ sold on the open market 200 shares of Gilead SciencesSEC Form 418 August 2025Common Stock · traded 15 August 2025 · filed 18 August 2025
- ▼ sold on the open market 3,000 shares of Gilead SciencesSEC Form 416 July 2025Common Stock · traded 15 July 2025 · filed 16 July 2025
- ▼ sold on the open market 3,000 shares of Gilead SciencesSEC Form 417 June 2025Common Stock · traded 16 June 2025 · filed 17 June 2025
- exercised options over 3,843 shares of Gilead Sciences (a derivative holding)SEC Form 411 June 2025Restricted Stock Unit · traded 10 June 2025 · filed 11 June 2025
- exercised options over 3,843 shares of Gilead SciencesSEC Form 411 June 2025Common Stock · traded 10 June 2025 · filed 11 June 2025
- had shares withheld for tax on 1,827 shares of Gilead SciencesSEC Form 411 June 2025Common Stock · traded 10 June 2025 · filed 11 June 2025
- exercised options over 12,500 shares of Gilead Sciences (a derivative holding)SEC Form 423 May 2025Non-qualified Stock Option (Right to Buy) · traded 22 May 2025 · filed 23 May 2025
- exercised options over 12,500 shares of Gilead Sciences (a derivative holding)SEC Form 423 May 2025Non-qualified Stock Option (Right to Buy) · traded 22 May 2025 · filed 23 May 2025
- exercised options over 12,500 shares of Gilead SciencesSEC Form 423 May 2025Common Stock · traded 22 May 2025 · filed 23 May 2025
- ▼ sold on the open market 12,500 shares of Gilead SciencesSEC Form 423 May 2025Common Stock · traded 22 May 2025 · filed 23 May 2025
- exercised options over 12,500 shares of Gilead SciencesSEC Form 423 May 2025Common Stock · traded 22 May 2025 · filed 23 May 2025
- ▼ sold on the open market 12,500 shares of Gilead SciencesSEC Form 423 May 2025Common Stock · traded 22 May 2025 · filed 23 May 2025
- ▼ sold on the open market 3,000 shares of Gilead SciencesSEC Form 423 May 2025Common Stock · traded 22 May 2025 · filed 23 May 2025
- was granted 3,318 shares of Neurocrine Biosciences (a derivative holding)SEC Form 422 May 2025Restricted Stock Unit · traded 21 May 2025 · filed 22 May 2025
- exercised options over 1,435 shares of Neurocrine Biosciences (a derivative holding)SEC Form 422 May 2025Restricted Stock Unit · traded 22 May 2025 · filed 22 May 2025
- exercised options over 1,435 shares of Neurocrine BiosciencesSEC Form 422 May 2025Common Stock · traded 22 May 2025 · filed 22 May 2025
- exercised options over 8,080 shares of Gilead Sciences (a derivative holding)SEC Form 412 March 2025Restricted Stock Unit · traded 10 March 2025 · filed 12 March 2025
- was granted 49,020 shares of Gilead Sciences (a derivative holding)SEC Form 412 March 2025Non-qualified Stock Option (Right to Buy) · traded 10 March 2025 · filed 12 March 2025
- was granted 11,090 shares of Gilead Sciences (a derivative holding)SEC Form 412 March 2025Restricted Stock Unit · traded 10 March 2025 · filed 12 March 2025
- exercised options over 8,080 shares of Gilead SciencesSEC Form 412 March 2025Common Stock · traded 10 March 2025 · filed 12 March 2025
- had shares withheld for tax on 3,907 shares of Gilead SciencesSEC Form 412 March 2025Common Stock · traded 10 March 2025 · filed 12 March 2025
- was granted 19,793 shares of Gilead SciencesSEC Form 46 February 2025Common Stock · traded 4 February 2025 · filed 6 February 2025
- was granted 70,712 shares of Gilead SciencesSEC Form 46 February 2025Common Stock · traded 4 February 2025 · filed 6 February 2025
- had shares withheld for tax on 45,666 shares of Gilead SciencesSEC Form 46 February 2025Common Stock · traded 4 February 2025 · filed 6 February 2025
- exercised options over 3,752 shares of Gilead Sciences (a derivative holding)SEC Form 411 December 2024Restricted Stock Unit · traded 10 December 2024 · filed 11 December 2024
- exercised options over 3,752 shares of Gilead SciencesSEC Form 411 December 2024Common Stock · traded 10 December 2024 · filed 11 December 2024
- had shares withheld for tax on 1,739 shares of Gilead SciencesSEC Form 411 December 2024Common Stock · traded 10 December 2024 · filed 11 December 2024
- ▼ sold on the open market 5,000 shares of Gilead SciencesSEC Form 47 November 2024Common Stock · traded 6 November 2024 · filed 7 November 2024
- ▼ sold on the open market 15,925 shares of Gilead SciencesSEC Form 413 September 2024Common Stock · traded 12 September 2024 · filed 13 September 2024
- ▼ sold on the open market 13,432 shares of Gilead SciencesSEC Form 413 September 2024Common Stock · traded 12 September 2024 · filed 13 September 2024
- exercised options over 3,752 shares of Gilead Sciences (a derivative holding)SEC Form 411 September 2024Restricted Stock Unit · traded 10 September 2024 · filed 11 September 2024
- exercised options over 3,752 shares of Gilead SciencesSEC Form 411 September 2024Common Stock · traded 10 September 2024 · filed 11 September 2024
- had shares withheld for tax on 1,734 shares of Gilead SciencesSEC Form 411 September 2024Common Stock · traded 10 September 2024 · filed 11 September 2024
- ▼ sold on the open market 9,513 shares of Gilead SciencesSEC Form 429 August 2024Common Stock · traded 28 August 2024 · filed 29 August 2024
- ▼ sold on the open market 5,490 shares of Gilead SciencesSEC Form 414 August 2024Common Stock · traded 13 August 2024 · filed 14 August 2024
- exercised options over 3,751 shares of Gilead Sciences (a derivative holding)SEC Form 411 June 2024Restricted Stock Unit · traded 10 June 2024 · filed 11 June 2024
- exercised options over 3,751 shares of Gilead SciencesSEC Form 411 June 2024Common Stock · traded 10 June 2024 · filed 11 June 2024
- had shares withheld for tax on 1,714 shares of Gilead SciencesSEC Form 411 June 2024Common Stock · traded 10 June 2024 · filed 11 June 2024
- was granted 1,435 shares of Neurocrine Biosciences (a derivative holding)SEC Form 423 May 2024Restricted Stock Unit · traded 22 May 2024 · filed 23 May 2024
- was granted 2,982 shares of Neurocrine Biosciences (a derivative holding)SEC Form 423 May 2024Non-Qualified Stock Option · traded 22 May 2024 · filed 23 May 2024
- exercised options over 2,100 shares of Neurocrine Biosciences (a derivative holding)SEC Form 421 May 2024Restricted Stock Unit · traded 17 May 2024 · filed 21 May 2024
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.